Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Quantum Helium de-risks Sagebrush production tests with new data

(Sharecast News) - AIM-listed Quantum Helium has revealed that a seismic review at its Sagebrush Helium Project in Colorado has materially de-risked the planned extended production test at the first well. The Sagebrush-1 well, first drilled in 1994, was confirmed as a dual oil and helium well with a helium concentration of 2.76%, with well data showing the presence of potential helium-bearing accumulation within the Leadville Formation.

Detailed prospect mapping will soon commence once final depth conversion is completed in the coming weeks.

"One of the primary objectives of the 3D seismic programme was to confirm that interpretation, and the new data has done exactly that - clearly validating the size, geometry and continuity of the Leadville structure we had previously mapped. The quality of the data is excellent and materially strengthens our confidence as we move towards testing the Leadville in Sagebrush-1," said Quantum's chief executive Howard McLaughlin.

Analysis also identified "encouraging" data that conforms closely with the original Sagebrush Ismay oil discovery, with the company now evaluating potential new oil drilling targets.

Meanwhile, further interpretation is ongoing at the company's southern Coyote Wash acreage. where it has already disclosed six drill-ready Leadville helium prospects, together with additional Ismay oil targets.

"Together, these preliminary results significantly de-risk the next phase of activity and reinforce the broader development and growth potential across both Sagebrush and Coyote Wash," McLaughlin said.

QHE shares were down 0.9% at 0.038p by 1429 GMT.

Share this article

Related Sharecast Articles

Thalia Therapeutics enters new phase of development
(Sharecast News) - Thalia Therapeutics said on Friday that it was entering a new phase of development ahead of its annual general meeting, with the proposed acquisition of Sanmirna Therapeutics and an oversubscribed £2.75m fundraising expected to accelerate its transition into a clinical-stage RNA therapeutics company.
Metir inks water system deal with Portsmouth Aviation
(Sharecast News) - Metir announced Friday that it has signed a memorandum of understanding with Portsmouth Aviation to evaluate integrated water treatment and monitoring systems combining Portsmouth's PaquaVida purification platform with Metir's Modern Water Microtox biological monitoring technology.
System1 reiterates rejection of Brave Bison's revised offer
(Sharecast News) - System1 reiterated its unanimous rejection of Brave Bison's revised cash-and-share proposal on Friday, saying feedback from major shareholders supported the board's view that the offer materially undervalued the company.
ConocoPhillips to buy 42% stake in BP Iraq oil fields
(Sharecast News) - BP said on Friday that it has agreed terms for ConocoPhillips to buy a 42% interest in BP Energy Company of Kirkuk (BP ECKL).

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.